Peptides for ADHD: What the science actually says

What did @tawniontiktok actually say?

The creator reported staying at her desk from 10 a.m. until 2:20 p.m., calling this evidence that a "focus peptide" is working. Her exact words: "that focus peptide is great." She did not name the specific peptide, mention a dose, or describe any mechanism. The video is essentially a personal anecdote framed as a product update, with a store link attached.

To be fair, she kept it vague. She did not claim to treat or cure ADHD, and she disclosed she was selling the product rather than hiding her commercial interest. But the hashtag #adhd does real work here, implicitly suggesting this is relevant to people with attention disorders, which is a claim she never actually makes out loud and cannot legally make.

Does the science back this up?

It depends entirely on which peptide she is actually selling, and we do not know. The most commonly marketed "focus peptides" in the telehealth and supplement space are semax and selank, both of which have at least some preliminary research behind them. But "preliminary" is doing heavy lifting there.

Semax, a synthetic analogue of ACTH, has been studied primarily in Russian clinical literature. A 2017 paper by Akhapkin et al. in the journal Zhurnal Nevrologii i Psikhiatrii reported cognitive effects in stroke recovery patients, not healthy adults or people with ADHD. Selank has shown anxiolytic effects in animal models and small human trials, but no peer-reviewed randomized controlled trial has demonstrated that either peptide improves sustained attention in adults with ADHD specifically. The honest summary: there is biological plausibility, and there is almost no robust human evidence.

What did they get wrong (or right)?

She did not get the science wrong, because she did not cite any science. That is itself a problem when you are selling a bioactive compound to people who may have real attention disorders.

What she got right: she described her own experience accurately, she disclosed the commercial relationship, and she did not make any dramatic medical claims. That puts her ahead of a lot of peptide content on TikTok.

What she got wrong, or at least incomplete: a person sitting at a desk for four hours is not a controlled experiment. Sleep, caffeine, task interest, and natural day-to-day variation in attention all affect focus. Without a baseline, a control condition, or any blinding, this is anecdote, not evidence. Attaching #adhd to that anecdote points vulnerable people toward an unproven, unregulated compound without telling them so.

• No peptide has FDA approval for ADHD.
• Semax and selank are not legal to sell as dietary supplements in the U.S. under current FDA guidance.
• Compounded peptides vary significantly in purity and concentration across suppliers.

What should you actually know?

If you have ADHD and a four-hour focus session sounds appealing, that feeling is completely understandable. But before spending money on an unnamed peptide from a TikTok store, there are things worth knowing.

First, the regulatory situation is genuinely murky. Many peptides marketed for cognitive performance exist in a legal gray zone. The FDA has placed several peptides, including BPC-157 and semax, on lists that restrict their compounding and sale. That does not mean they are dangerous, but it does mean quality control is inconsistent and you are largely on your own if something goes wrong.

Second, the placebo effect on attention tasks is well-documented and not trivial. A 2014 meta-analysis by Doering et al. in PLOS ONE found meaningful placebo responses in cognitive performance trials. Believing a compound will help your focus can genuinely change how you perform, at least short-term.

Third, if you suspect you have ADHD, an actual clinical evaluation is the appropriate starting point. Evidence-based treatments, including stimulant medications and behavioral strategies, have decades of controlled trial data behind them. A TikTok update about a four-hour desk session does not.

The bottom line

@tawniontiktok shared a personal experience and did not wildly overstate it. But the #adhd hashtag, the store link, and the lack of any identified compound create a situation where viewers may spend real money on an unregulated product based on one person's good afternoon. That is worth naming plainly. Personal anecdote is not clinical evidence, and a great focus day is not a treatment outcome.